Blog

Heartware Ventricular Assist System Pump Connector Failure Could Lead to Death: Manufacturer Reissues Warning Following FDA Class 1 Recall Issued

April 29, 2014

Followup to December 2013 Class 1 recall of the HeartWare, Inc. Heartware Ventricular Assist System In December of last year, the FDA issued its most serious recall, Class 1, for the HeartWare, Inc. “Heartware Ventricular Assist System” pump mechanism. The manufacturer followed up yesterday by reissuing a warning to physicians following additional reports of device… Continue reading

Accidents & Catastrophic Injury

April 10, 2014

Harman Attorneys Know Accident and Injury Law When you or a loved one is an innocent victim of an accident or the negligence and wrongdoing of others, contact our firm immediately at . At Harman Law LLC, we focus on clients with the most severe catastrophic injury and wrongful death matters: auto, motorcycle and truck… Continue reading

Philips Brand Trilogy Ventilator Recall: Failure Could Cause Serious Injury or Death

March 7, 2014

Trilogy Ventilator power management boards have been recalled due to a failure in the system that could interrupt or stop the mechanical breathing in the continuous or intermittent ventilator support for patients. The failure in the Philips Brand Trilogy Ventilator could lead to serious injury or death. The FDA issued a Class 1 recall on… Continue reading

Harman & Fredrickson CLE: The Shifting Landscape of Medical Device Preemption

February 27, 2014

At the 22nd Annual Product Liability Seminar Continuing Legal Education (CLE) of the State Bar of Georgia, attorneys Matt Harman and Eric Fredrickson prepared a session on medical device preemption. Eric Fredrickson presented the information to the assembled attorneys on February 26, 2014. The key takeaway for plaintiff’s attorneys in medical device cases that call… Continue reading

Testosterone Therapy Rx Linked to Increased Risk of Heart Attack, Stroke and Potentially Fatal Conditions

February 6, 2014

Study Says Risk of Heart Attack Increases 2-3x for Men Taking Testosterone Therapy, Also Risk of Stroke, Pulmonary Embolism and Blood Clots A study published by the Public Library of Science One (PLoS One) found an association between testosterone therapy (TT) and cardiovascular disease. The risk for heart attack in men under the age of… Continue reading

UPDATE: Testosterone Therapy Rx Linked to Potentially Fatal Conditions

February 6, 2014

Follow up to February 2014 Harman Law Post: FDA Requires Label Change Citing Increased Blood Clot Risk with Testosterone Products On June 19, 2014 the FDA announced they are requiring manufacturers of testosterone therapy products (“TT”) to add blood clot warnings to the drug labeling. The testosterone products include: Axiron AndroDerm AndroGel (the biggest seller… Continue reading

Ventilator Recall: FDA Says Puritan Bennett by Covidien May Stop, Causing Patient Injury or Death

January 10, 2014

Today the FDA issued and posted a Class 1 recall, the most serious, for the Puritan Bennett 840 Series Ventilator by Covidien saying a software glitch may cause the device to stop working, preventing air from reaching patients who may not be able to breathe on their own and causing serious injury or death. “Class… Continue reading

Justice: We Level The Playing Field

January 3, 2014

Accidents, injuries and happen. Justice should be yours. When accidents happen through no fault of your own, or you’re taken advantage of financially, the attorneys at Harman Law know how to level the playing field to fight for the justice you deserve. Why choose Harman Law? Watch Matt Harman and his team plan their strategy… Continue reading

GSK: No More Payments to Doctors

December 18, 2013

by Eric Fredrickson, Esq., Harman Law LLC GlaxoSmithKline has announced major changes to its drug marketing efforts. First, the sixth largest pharmaceutical manufacturer will stop paying doctors to promote its drugs. Second, GlaxoSmithKline will no longer tie the compensation of its sales representatives to the number of prescriptions written. These are very welcome developments for… Continue reading

Seizure Drug Onfi May Cause Rare But Potentially Fatal Reactions

December 6, 2013

The FDA announced this week that the drug Onfi (clobazam), manufactured by Lundbeck, Inc. “can cause rare but serious skin reactions that can result in permanent harm and death.” All cases known by the FDA have resulted in hospitalization, including one patient who became blind and another who died. Several lawsuits have been filed on… Continue reading

Heartware Ventricular Assist System Pump Connector Failure Could Lead to Death: Manufacturer Reissues Warning Following FDA Class 1 Recall Issued

Accidents & Catastrophic Injury

Philips Brand Trilogy Ventilator Recall: Failure Could Cause Serious Injury or Death

Harman & Fredrickson CLE: The Shifting Landscape of Medical Device Preemption

Testosterone Therapy Rx Linked to Increased Risk of Heart Attack, Stroke and Potentially Fatal Conditions

UPDATE: Testosterone Therapy Rx Linked to Potentially Fatal Conditions

Ventilator Recall: FDA Says Puritan Bennett by Covidien May Stop, Causing Patient Injury or Death

Justice: We Level The Playing Field

GSK: No More Payments to Doctors

Seizure Drug Onfi May Cause Rare But Potentially Fatal Reactions

Practice Areas

Contact Us

Testimonials

Harman Law Firm

Atlanta

Augusta